Birdwatch Note
2024-12-14 07:46:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The contents of mRNA Covid vaccinations have been widely published and known since before they were publicly available. The ingredients and vaccines have been extensively tested for safety and efficacy. Phase 3 Trials https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 https://www.nejm.org/doi/full/10.1056/NEJMoa2035389 Comprehensive Reviews of Ingredients and Safety https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227007/ https://doi.org/10.1016/j.vaccine.2021.12.056
Written by 10B1FDF50BEBD7A3AD50F08E412806B914FC70C962B6CEBCAC02D3F8644D31F9
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1867651523989450909
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1867838547392442843
- noteId - 1867838547392442843
- participantId -
- noteAuthorParticipantId - 10B1FDF50BEBD7A3AD50F08E412806B914FC70C962B6CEBCAC02D3F8644D31F9 Participant Details
- createdAtMillis - 1734162387118
- tweetId - 1867651523989450909
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The contents of mRNA Covid vaccinations have been widely published and known since before they were publicly available. The ingredients and vaccines have been extensively tested for safety and efficacy. Phase 3 Trials https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 https://www.nejm.org/doi/full/10.1056/NEJMoa2035389 Comprehensive Reviews of Ingredients and Safety https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227007/ https://doi.org/10.1016/j.vaccine.2021.12.056
Note Ratings
rated at | rated by | |
2024-12-14 18:58:10 -0600 | Rating Details | |
2024-12-14 16:41:24 -0600 | Rating Details | |
2024-12-14 15:58:52 -0600 | Rating Details | |
2024-12-14 13:44:44 -0600 | Rating Details | |
2024-12-14 13:34:49 -0600 | Rating Details | |
2024-12-14 12:54:41 -0600 | Rating Details | |
2024-12-14 12:10:01 -0600 | Rating Details | |
2024-12-14 11:55:45 -0600 | Rating Details | |
2024-12-14 11:47:56 -0600 | Rating Details | |
2024-12-14 11:12:44 -0600 | Rating Details | |
2024-12-14 11:10:09 -0600 | Rating Details | |
2024-12-14 10:56:46 -0600 | Rating Details | |
2024-12-14 10:54:56 -0600 | Rating Details | |
2024-12-14 10:47:53 -0600 | Rating Details | |
2024-12-14 10:36:05 -0600 | Rating Details | |
2024-12-14 10:16:48 -0600 | Rating Details | |
2024-12-14 10:06:56 -0600 | Rating Details | |
2024-12-14 09:25:26 -0600 | Rating Details | |
2024-12-14 08:25:36 -0600 | Rating Details | |
2024-12-14 08:24:59 -0600 | Rating Details | |
2024-12-14 07:46:29 -0600 | Rating Details | |
2024-12-14 07:42:25 -0600 | Rating Details | |
2024-12-14 07:35:39 -0600 | Rating Details | |
2024-12-14 07:32:41 -0600 | Rating Details | |
2024-12-14 07:32:04 -0600 | Rating Details | |
2024-12-14 06:51:06 -0600 | Rating Details | |
2024-12-14 05:46:46 -0600 | Rating Details | |
2024-12-14 05:13:56 -0600 | Rating Details | |
2024-12-14 04:54:43 -0600 | Rating Details | |
2024-12-14 04:43:10 -0600 | Rating Details | |
2024-12-14 03:58:52 -0600 | Rating Details | |
2024-12-14 03:20:09 -0600 | Rating Details | |
2024-12-14 02:25:50 -0600 | Rating Details | |
2024-12-14 02:24:08 -0600 | Rating Details | |
2024-12-14 01:48:39 -0600 | Rating Details | |
2024-12-15 05:20:38 -0600 | Rating Details | |
2024-12-14 23:11:24 -0600 | Rating Details | |
2024-12-15 03:18:59 -0600 | Rating Details | |
2024-12-14 22:29:13 -0600 | Rating Details |